Literature DB >> 15237856

Clinical perspectives on xenobiotic-induced hepatotoxicity.

Basuki Gunawan1, Neil Kaplowitz.   

Abstract

Drug-induced hepatotoxicity is an important cause of liver disease with significant medical, economic, legal, and regulatory implications. Clinically, it presents a diagnostic challenge to health care professionals since drug-induced liver disease can mimic the clinicopathologic features of all other acute and chronic liver diseases. However, individual drugs tend to have a characteristic clinical signature. Early identification of hepatotoxicity by either laboratory monitoring or patients' awareness as a result of education may avert serious liver injury in delayed idiosyncratic toxicity. Most adverse hepatic reactions require metabolism of the drug to reactive metabolites and free radicals, which then either lead to direct overwhelming lethal insult, nonlethal sensitization to the lethal effects of the innate immune system, or haptenization eliciting an immunoallergic response of the adaptive immune system. Besides licensed drugs, herbal and natural supplements are recognized as causing hepatotoxicity with increasing frequency as patients turn more and more to alternative medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237856     DOI: 10.1081/dmr-120034148

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  23 in total

Review 1.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 2.  Drug-induced liver injury: review article.

Authors:  Wissam Bleibel; Stephen Kim; Karl D'Silva; Eric R Lemmer
Journal:  Dig Dis Sci       Date:  2007-03-16       Impact factor: 3.199

3.  Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

Authors:  Jiekun Xuan; Si Chen; Baitang Ning; William H Tolleson; Lei Guo
Journal:  Chem Biol Interact       Date:  2015-10-22       Impact factor: 5.192

4.  Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database.

Authors:  Naomi Jessurun; Eugene van Puijenbroek
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

Review 5.  Drug-induced liver injury.

Authors:  Gebran Abboud; Neil Kaplowitz
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia.

Authors:  Rolf Teschke; Johannes Schulze
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

7.  Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potential.

Authors:  Sandipan Datta; Fakhri Mahdi; Zulfiqar Ali; Mika B Jekabsons; Ikhlas A Khan; Dale G Nagle; Yu-Dong Zhou
Journal:  J Nat Prod       Date:  2013-12-11       Impact factor: 4.050

Review 8.  Mechanisms of drug-induced liver injury.

Authors:  Michael P Holt; Cynthia Ju
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 9.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 10.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.